Sleep Medicine News

DENVER — Patients with idiopathic hypersomnia have higher odds of comorbidities both related and unrelated to sleep, Jed Black, MD, says in this Healio video from the American Academy of Neurology annual meeting.

Takeda has reported positive results from a phase 2b clinical trial of an investigational, oral orexin receptor agonist for narcolepsy type 1.

DENVER — For the glymphatic system of the brain to function properly, individuals must pay attention to their sleep duration, regulation and deprivation, according to a presenter at the American Academy of Neurology annual meeting.

Insufficient sleep was tied to poorer cognition and attention in adolescents who were classified as having overweight or obesity based on their BMI compared with those with normal weight, according to a recent study in JAMA Neurology.

Persistent shorter sleep durations during childhood were associated with a greater risk of psychosis disorder and psychotic episodes during early adulthood, a study in JAMA Psychiatry showed.

DENVER — For those diagnosed with migraine, gastrointestinal issues or both, psychiatric comorbidities increase the risk of worsened physical and mental states, according to an expert at the American Academy of Neurology annual meeting.

DENVER — Cognitive impairment in Parkinson’s is a mitigating factor for presence of blood-based biomarkers during sleep as indicator of disease progression, according to a poster at the American Academy of Neurology annual meeting.

DENVER — In adults with multiple sclerosis, obstructive sleep apnea increases brain atrophy independent of obesity, a common comorbidity, according to a poster at the American Academy of Neurology annual meeting.

Patients with dry eye disease have worse sleep quality and may be at greater risk for unhealthy sleep duration, although a causal relationship between dry eye and sleep disorder has not been established, according to a meta-analysis.

Philips Respironics and Philips Holding USA agreed to the FDA’s finalized consent decree against the company, according to a company press release.